Search Results - "Abratt, Raymond P."

Vandetanib Plus Pemetrexed for the Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer: A Randomized, Double-Blind Phase III Trial by DE BOER, Richard H, ARRIETA, Oscar, LANGMUIR, Peter, MILENKOVA, Tsveta, READ, Jessica, VANSTEENKISTE, Johan F, YANG, Chih-Hsin, GOTTFRIED, Maya, CHAN, Valorie, RAATS, Johann, DE MARINIS, Filippo, ABRATT, Raymond P, WOLF, Jürgen, BLACKHALL, Fiona H

“…Vandetanib is a once-daily oral inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling. This randomized,…”
Get full text

Patient care and staff well-being in oncology during the coronavirus pandemic – ethical considerations by Abratt, Raymond P.

“…At the time of writing this article, the world is severely disrupted by the coronavirus disease (Covid-19) virus. This unprecedented pandemic will last many…”
Get full text

Phase III Study Comparing Oral Topotecan to Intravenous Docetaxel in Patients With Pretreated Advanced Non–Small-Cell Lung Cancer by RAMLAU, Rodryg, GERVAIS, Radj, SHEPHERD, Frances A, KRZAKOWSKI, Maciej, VON PAWEL, Joachim, KAUKEL, Eckhard, ABRATT, Raymond P, DHARAN, Bernie, GROTZINGER, Kelly M, ROSS, Graham, DANE, Graham

“…This open-label, randomized, multicenter, phase III study compared oral topotecan versus intravenous (IV) docetaxel in patients with previously treated…”
Get full text

Neutron therapy and increased late complication rates by Abratt, Raymond P

Get full text

Stereotactic Ablative Body Radiotherapy for Metastases Needs Better Evidence by Macbeth, Fergus R, Abratt, Raymond P

Get more information

Modelling cost-effective therapies by Abratt, Raymond P

Get full text

Who will guard the guards? Medical leadership and conflict of interest in South African healthcare by Abratt, Raymond P

Get full text

Short-course adjuvant trastuzumab will increase cure rates in patients with human epidermal growth factor receptor 2-positive breast cancer by Abratt, Raymond P.

“…Internationally, breast cancer is the commonest cancer in women, comprising 25% of cancers. It is also the most frequent cause of cancer death in women,…”
Get full text

Cost considerations in determining the affordability of adjuvant trastuzumab in breast cancer by Abratt, Raymond P., Szpak, Waldemar

“…Cost considerations in determining affordability are extremely important for the sustainable health policy of all countries. It is of utmost importance that…”
Get full text

Hypofractionated irradiation for non-small cell lung cancer by Abratt, Raymond P., Bogart, Jeffrey A., Hunter, Alistair

“…Large radiation fractions are an effective way of killing tumour cells but have generally been avoided in curative treatment of patients because of concerns of…”
Get full text

Professional competence- adding reflective elements to case reports by Abratt, Raymond P

Get full text

First South African Congress of Oncology 2019 by van Heerden, M

“…Abstract only…”
Get full text

Cancer care in South Africa by Abratt, Raymond P, Dreosti, Lydia, Ruff, Paul

“…ICON has implemented cost-effective treatment protocols and is developing a financially sustainable model within the private sector, but this sector represents…”
Get full text

Lung toxicity following chest irradiation in patients with lung cancer by Abratt, Raymond P, Morgan, Graeme W

“…Classical radiation pneumonitis has been described after single dose whole lung irradiation in experimental animals where above a threshold dose of…”
Get full text

The fast neutron therapy programme for patients in South Africa should come to an end by Abratt, Raymond Pierre

Get full text

Lung cancer management in limited resource settings: Guidelines for appropriate good care by Macbeth, Fergus R, Abratt, Raymond P, Cho, Kwan H, Stephens, Richard J, Jeremic, Branislav

“…Abstract Lung cancer is a major cause of cancer death worldwide and is becoming an increasing problem in developing countries. It is important that, in…”
Get full text

Pulmonary complications of radiation therapy by Abratt, Raymond P, Morgan, Graeme W, Silvestri, Gerard, Willcox, Paul

“…There have been important developments in understanding the difference in pathogenesis and clinical significance between acute or sporadic pneumonitis and late…”
Get more information

A randomized, double-blind, placebo-controlled phase II study of vandetanib plus docetaxel/prednisolone in patients with hormone-refractory prostate cancer by Horti, József, Widmark, Anders, Stenzl, Arnulf, Federico, Miriam H, Abratt, Raymond P, Sanders, Nick, Pover, Gillian M, Bodrogi, István

“…Vandetanib (ZACTIMA) is a once-daily oral anticancer drug that selectively inhibits vascular endothelial growth factor receptor, epidermal growth factor…”
Get more information

Accreditation of training courses in good clinical practice by Abratt, Raymond P, Hunter, Alistair J

Get full text

Accreditation of training courses in good clinical practice by Abratt, Raymond P, Hunter, Alistair J

Get full text